# Concurrent Chronic-Plus-Binge Alcohol Consumption and Nicotine Vaping Alter the Cardiac Ventricular Proteome in a Preclinical Mouse Model

**Authors:** Nicholas R. Harris, Eden M. Gallegos, Meagan Donovan, Amirsalar Mansouri, Janos Paloczi, Jason D. Gardner

PMC · DOI: 10.3390/ijms27041625 · 2026-02-07

## TL;DR

This study shows that combining chronic alcohol use with nicotine vaping affects heart proteins in mice in complex, non-additive ways.

## Contribution

The study reveals nonadditive effects of concurrent alcohol and nicotine vaping on cardiac proteomes in a preclinical model.

## Key findings

- 201 proteins were altered by ethanol, 101 by nicotine vaping, and 159 by combined exposure.
- Both ethanol and nicotine vaping affected lipid homeostasis, extracellular matrix, and mitochondrial pathways.
- Combined exposure showed nonadditive effects, suggesting interaction-dependent changes in protein expression.

## Abstract

Nicotine vaping has surged in recent years, particularly among young adults, and is strongly linked with concurrent alcohol use. Separately, chronic excessive alcohol use drives hypertension and cardiomyopathy, while nicotine vaping is linked to a modest rise in cardiovascular disease incidence and mortality. However, little is known about how concurrent use interacts to affect protein expression in the cardiovascular system. The aim of this study was to determine differential cardiac protein expression in mice exposed to concurrent chronic-plus-binge alcohol and nicotine vaping use. Male C57BL6/J mice received a 20-day 5% ethanol diet with 5 g/kg ethanol binges on days 10 and 20, alongside isocaloric controls. During this period, they were also exposed nightly to either 5% nicotine salt vapor, vegetable glycerin/propylene glycol vehicle vapor, or room air. The left ventricular free wall was collected and analyzed using discovery-based proteomics and subsequent Ingenuity Pathway Analysis. A total of 3144 proteins were identified across all groups. Compared to air-exposed, control-fed mice, 201 proteins were significantly altered by ethanol, 101 proteins by nicotine vaping, and 159 proteins by combined exposure. Both ethanol and nicotine vaping influenced pathways involved in lipid homeostasis, extracellular matrix remodeling, and mitochondrial bioenergetics; however, these alterations did not uniformly manifest in the dual-use group. This pattern highlights the nonadditive and potentially interaction-dependent nature of alcohol and nicotine vaping effects on cardiovascular protein expression patterns that may contribute to a distinct functional phenotype.

## Linked entities

- **Chemicals:** ethanol (PubChem CID 702), nicotine (PubChem CID 942), propylene glycol (PubChem CID 1030)
- **Diseases:** cardiomyopathy (MONDO:0004994), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** Akap1 (A kinase anchor protein 1) [NCBI Gene 11640] {aka AKAP121, AKAP84, Akap, DAKAP1, S-AKAP84}, Hspa2 (heat shock protein family A (Hsp70) member 2) [NCBI Gene 15512] {aka 70kDa, HSP70.2, HSP70A2, Hsp70-2}, Uggt1 (UDP-glucose glycoprotein glucosyltransferase 1) [NCBI Gene 320011] {aka 0910001L17Rik, A930007H10Rik, C820010P03Rik, GT, UGT1, Ugcgl1}, Ide (insulin degrading enzyme) [NCBI Gene 15925] {aka 1300012G03Rik, 4833415K22Rik}, Hspb6 (heat shock protein family B (small) member 6) [NCBI Gene 243912] {aka Gm479, Hsp20}, Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) [NCBI Gene 17999] {aka E430025J12Rik, EG639396, Gm7265, KIAA0093, Nedd4-1, Nedd4a}, Vps4b (vacuolar protein sorting 4B) [NCBI Gene 20479] {aka 8030489C12Rik, Skd1}, Adrb1 (adrenergic receptor, beta 1) [NCBI Gene 11554] {aka Adrb-1, beta-AR}, Mogs (mannosyl-oligosaccharide glucosidase) [NCBI Gene 57377] {aka 1810017N02Rik, Gcs1}, Myh7 (myosin, heavy polypeptide 7, cardiac muscle, beta) [NCBI Gene 140781] {aka B-MHC, MYH-beta/slow, MyHC-I, Myhc-b, Myhcb, beta-MHC}, COX3 (cytochrome c oxidase subunit III) [NCBI Gene 17710], Lpl (lipoprotein lipase) [NCBI Gene 16956], Vps4a (vacuolar protein sorting 4A) [NCBI Gene 116733] {aka 4930589C15Rik}, Gpam (glycerol-3-phosphate acyltransferase, mitochondrial) [NCBI Gene 14732] {aka GPAT, GPAT-1, GPAT1, P90}, Acot1 (acyl-CoA thioesterase 1) [NCBI Gene 26897] {aka ACH2, CTE-1, CTE-I, Cte1, D12Ucla1}, Gm12551 (perilipin 2 pseudogene) [NCBI Gene 101055843], Mrpl1 (mitochondrial ribosomal protein L1) [NCBI Gene 94061] {aka 2410002L03Rik, 5830418D04Rik, L1mt}, Psmd8 (proteasome (prosome, macropain) 26S subunit, non-ATPase, 8) [NCBI Gene 57296] {aka 6720456J22Rik}, Slc27a4 (solute carrier family 27 (fatty acid transporter), member 4) [NCBI Gene 26569] {aka ACSVL4, FATP4}, Fbxo22 (F-box protein 22) [NCBI Gene 71999] {aka 0610033L19Rik, 1600016C16Rik}, Sparc (secreted acidic cysteine rich glycoprotein) [NCBI Gene 20692] {aka BM-40, ON}, Gpx3 (glutathione peroxidase 3) [NCBI Gene 14778] {aka EGPx, GPx, GSHPx-3, GSHPx-P}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Acot2 (acyl-CoA thioesterase 2) [NCBI Gene 171210] {aka MTE-I, Mte1}, Camk2g (calcium/calmodulin-dependent protein kinase II gamma) [NCBI Gene 12325] {aka Camkg}, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) [NCBI Gene 17888] {aka A830009F23Rik, Myhc-a, Myhca, alpha-MHC, alphaMHC}, Cdkn1b (cyclin dependent kinase inhibitor 1B) [NCBI Gene 12576] {aka Kip1, p27, p27Kip1}, Pkia (protein kinase inhibitor, alpha) [NCBI Gene 18767] {aka PKIalpha}, Adam10 (a disintegrin and metallopeptidase domain 10) [NCBI Gene 11487] {aka 1700031C13Rik, MADM, kuz, kuzbanian}, Mrpl32 (mitochondrial ribosomal protein L32) [NCBI Gene 75398] {aka 0610033O15Rik}, Pkig (protein kinase inhibitor, gamma) [NCBI Gene 18769] {aka PKIgamma}, Mrpl53 (mitochondrial ribosomal protein L53) [NCBI Gene 68499] {aka 1110007K17Rik}, Pnpla8 (patatin-like phospholipase domain containing 8) [NCBI Gene 67452] {aka 1200006O19Rik, Ipla2(gamma)}, Col5a2 (collagen, type V, alpha 2) [NCBI Gene 12832] {aka 1110014L14Rik}, Hspa1a (heat shock protein family A (Hsp70) member 1A) [NCBI Gene 193740] {aka Hsp70-3, Hsp70.3, Hsp72, hsp68, hsp70A1}, Ces1c (carboxylesterase 1C) [NCBI Gene 13884] {aka Ces-N, Ee-1, Ee1, Es-4, Es-N, Es1}
- **Diseases:** hypertension (MESH:D006973), lethargy (MESH:D053609), weight loss (MESH:D015431), toxicity (MESH:D064420), cardiovascular disease (MESH:D002318), dilated cardiomyopathy (MESH:D002311), atrial fibrillation (MESH:D001281), hypertrophy (MESH:D006984), atrial enlargement (MESH:D006332), hypertrophic remodeling (MESH:D020257), hypertrophic (MESH:D002312), pulmonary fibrosis (MESH:D011658), cardiac injury (MESH:D006331), heart failure (MESH:D006333), alcohol use disorder (MESH:D000437), Mitochondrial dysfunction (MESH:D028361), injury to (MESH:D014947), inflammatory (MESH:D007249), left ventricular (LV) dilation (MESH:C565277), fibrosis (MESH:D005355), cardiomyopathy (MESH:D009202), stroke (MESH:D020521), steatosis (MESH:D005234), obese (MESH:D009765), NPC (MESH:D052556), arrhythmic episodes (OMIM:212500), pain or distress (MESH:D012128)
- **Chemicals:** glycerin (MESH:D005990), superoxide (MESH:D013481), BioRender (-), MD (MESH:D008573), ammonium bicarbonate (MESH:C027043), PG (MESH:D019946), acetone (MESH:D000096), fatty acid (MESH:D005227), Nicotine (MESH:D009538), picrosirius red (MESH:C009798), urea (MESH:D014508), lipid (MESH:D008055), reactive oxygen species (MESH:D017382), calcium (MESH:D002118), PBS (MESH:D007854), Alcohol (MESH:D000438), Cotinine (MESH:D003367), tris(2-carboxyethyl)phosphine (MESH:C080938), formic acid (MESH:C030544), glycerophospholipids (MESH:D020404), sodium deoxycholate (MESH:D003840), acetonitrile (MESH:C032159), triglyceride (MESH:D014280), lipid peroxide (MESH:D008054), benzoic acid (MESH:D019817), EDTA (MESH:D004492), nitrogen (MESH:D009584), isoflurane (MESH:D007530), iodoacetamide (MESH:D007460), ETOH (MESH:D000431)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940285/full.md

---
Source: https://tomesphere.com/paper/PMC12940285